Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cayman Chemical R4AmIno3hydroxybutyrIc 50mg
SDP

Supplier:  Cayman Chemical 3153250 MG

Encompass_Preferred

A PPAR agonist 750- and 2500-fold selective for PPAR over PPARa and PPARY reduces increases in fasting blood glucose and serum insulin levels and decreases insulin resistance in Alms1 mutant (foz/foz) mice fed an atherogenic diet as a model of diet-induced obesity type 2 diabetes and NASH at 10 mg/kg per day for eight weeks decreases serum ALT as well as serum and hepatic cholesterol and triglyceride levels and reduces markers of NASH in the same model

Catalog No. 50-299-1087


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.